Correction to: Osimertinib: A Review in Previously Untreated, EGFR Mutation-Positive, Advanced NSCLC
Crossref DOI link: https://doi.org/10.1007/s11523-021-00853-y
Published Online: 2021-10-25
Published Print: 2021-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lamb, Yvette N.
Text and Data Mining valid from 2021-10-25
Version of Record valid from 2021-10-25
Article History
First Online: 25 October 2021